Orchard Therapeutics PLC
Lindsay Leigh Gabrielson is a seasoned payroll professional with extensive experience in managing domestic and international payroll operations across multiple industries. Currently serving as Global Payroll Manager at Orchard Therapeutics since June 2021, Lindsay has a proven track record in enhancing payroll systems, ensuring compliance with government regulations, and leading successful initiatives like payroll schedule conversions and new entity setups in various countries. Previous roles include Sr Manager of Global Payroll at Empirix and Payroll & HRIS Manager at Aspen Aerogels, where Lindsay demonstrated a commitment to improving payroll processes and employee engagement. Recognized for achievements in system implementations and employee morale enhancements, Lindsay’s expertise encompasses payroll analytics, HRIS management, compliance auditing, and employee benefits administration. Educational background includes studies at Middlesex Community College and the University of New Hampshire, complemented by various training seminars.
This person is not in any offices
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.